Screening for vancomycin-resistant enterococci with Xpert® vanA/vanB: diagnostic accuracy and impact on infection control decision making

Vancomycin-resistant enterococci (VRE) are increasingly important nosocomial pathogens and screening for colonization status is a mainstay in infection control. We implemented PCR-based screening during vanA-positive Enterococcus faecium outbreaks in four university hospitals in Copenhagen, Denmark....

Full description

Bibliographic Details
Main Authors: B.J. Holzknecht, D.S. Hansen, L. Nielsen, A. Kailow, J.O. Jarløv
Format: Article
Language:English
Published: Elsevier 2017-03-01
Series:New Microbes and New Infections
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2052297516301573
id doaj-b414cea2a83c460fbafc6b1366b06abb
record_format Article
spelling doaj-b414cea2a83c460fbafc6b1366b06abb2020-11-25T02:12:47ZengElsevierNew Microbes and New Infections2052-29752017-03-0116C545910.1016/j.nmni.2016.12.020Screening for vancomycin-resistant enterococci with Xpert® vanA/vanB: diagnostic accuracy and impact on infection control decision makingB.J. HolzknechtD.S. HansenL. NielsenA. KailowJ.O. JarløvVancomycin-resistant enterococci (VRE) are increasingly important nosocomial pathogens and screening for colonization status is a mainstay in infection control. We implemented PCR-based screening during vanA-positive Enterococcus faecium outbreaks in four university hospitals in Copenhagen, Denmark. Xpert® vanA/vanB was performed directly on rectal swabs and the vanA PCR result was used to guide infection control measures. Concurrently, all samples were selectively cultured including an overnight enrichment step. Diagnostic accuracy was calculated as well as turnaround time and the impact of the earlier available PCR results on infection control decision making. In all, 1110 samples were analysed. The vanA PCR positivity rate was 13.8% and culture positivity rate was 15.2%. The diagnostic accuracy of the vanA part of the assay was high with a sensitivity of 87.1%, a specificity of 99.7%, and positive and negative predictive values of 98.0% and 97.7%, respectively. The vanB PCR had a considerably lower specificity of 77.6% and a positive predictive value of 0.4%. In 1067 (96.1%) samples, PCR results were reported within 1 day, whereas median culture turnaround time was 3 days. The saving of time to available results corresponded to 141 saved isolation days and 292 saved transmission risk days. False-negative or false-positive PCR results led to six additional transmission risk days and 13 additional isolation days, respectively. The vanA PCR had high diagnostic accuracy and the prompt availability of results gave a considerable benefit for infection control decision making.http://www.sciencedirect.com/science/article/pii/S2052297516301573Infection controlmolecular screeningPCR-based screeningselective culturevanAvancomycin-resistant enterococci
collection DOAJ
language English
format Article
sources DOAJ
author B.J. Holzknecht
D.S. Hansen
L. Nielsen
A. Kailow
J.O. Jarløv
spellingShingle B.J. Holzknecht
D.S. Hansen
L. Nielsen
A. Kailow
J.O. Jarløv
Screening for vancomycin-resistant enterococci with Xpert® vanA/vanB: diagnostic accuracy and impact on infection control decision making
New Microbes and New Infections
Infection control
molecular screening
PCR-based screening
selective culture
vanA
vancomycin-resistant enterococci
author_facet B.J. Holzknecht
D.S. Hansen
L. Nielsen
A. Kailow
J.O. Jarløv
author_sort B.J. Holzknecht
title Screening for vancomycin-resistant enterococci with Xpert® vanA/vanB: diagnostic accuracy and impact on infection control decision making
title_short Screening for vancomycin-resistant enterococci with Xpert® vanA/vanB: diagnostic accuracy and impact on infection control decision making
title_full Screening for vancomycin-resistant enterococci with Xpert® vanA/vanB: diagnostic accuracy and impact on infection control decision making
title_fullStr Screening for vancomycin-resistant enterococci with Xpert® vanA/vanB: diagnostic accuracy and impact on infection control decision making
title_full_unstemmed Screening for vancomycin-resistant enterococci with Xpert® vanA/vanB: diagnostic accuracy and impact on infection control decision making
title_sort screening for vancomycin-resistant enterococci with xpert® vana/vanb: diagnostic accuracy and impact on infection control decision making
publisher Elsevier
series New Microbes and New Infections
issn 2052-2975
publishDate 2017-03-01
description Vancomycin-resistant enterococci (VRE) are increasingly important nosocomial pathogens and screening for colonization status is a mainstay in infection control. We implemented PCR-based screening during vanA-positive Enterococcus faecium outbreaks in four university hospitals in Copenhagen, Denmark. Xpert® vanA/vanB was performed directly on rectal swabs and the vanA PCR result was used to guide infection control measures. Concurrently, all samples were selectively cultured including an overnight enrichment step. Diagnostic accuracy was calculated as well as turnaround time and the impact of the earlier available PCR results on infection control decision making. In all, 1110 samples were analysed. The vanA PCR positivity rate was 13.8% and culture positivity rate was 15.2%. The diagnostic accuracy of the vanA part of the assay was high with a sensitivity of 87.1%, a specificity of 99.7%, and positive and negative predictive values of 98.0% and 97.7%, respectively. The vanB PCR had a considerably lower specificity of 77.6% and a positive predictive value of 0.4%. In 1067 (96.1%) samples, PCR results were reported within 1 day, whereas median culture turnaround time was 3 days. The saving of time to available results corresponded to 141 saved isolation days and 292 saved transmission risk days. False-negative or false-positive PCR results led to six additional transmission risk days and 13 additional isolation days, respectively. The vanA PCR had high diagnostic accuracy and the prompt availability of results gave a considerable benefit for infection control decision making.
topic Infection control
molecular screening
PCR-based screening
selective culture
vanA
vancomycin-resistant enterococci
url http://www.sciencedirect.com/science/article/pii/S2052297516301573
work_keys_str_mv AT bjholzknecht screeningforvancomycinresistantenterococciwithxpertvanavanbdiagnosticaccuracyandimpactoninfectioncontroldecisionmaking
AT dshansen screeningforvancomycinresistantenterococciwithxpertvanavanbdiagnosticaccuracyandimpactoninfectioncontroldecisionmaking
AT lnielsen screeningforvancomycinresistantenterococciwithxpertvanavanbdiagnosticaccuracyandimpactoninfectioncontroldecisionmaking
AT akailow screeningforvancomycinresistantenterococciwithxpertvanavanbdiagnosticaccuracyandimpactoninfectioncontroldecisionmaking
AT jojarløv screeningforvancomycinresistantenterococciwithxpertvanavanbdiagnosticaccuracyandimpactoninfectioncontroldecisionmaking
_version_ 1724908217946865664